Clinical importance of calcium-sensing receptor gene polymorphism Arg990 Gly in the age of calcimimetic therapy

Current Pharmacogenomics

Volumn 4, Issue 2, 2006, Pages 153-156

  Rothe, Hansjörg ^b   Mayer, Gert ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b Kuratorium für Dialyse und Nierentransplantation ^*  (Germany)

Author keywords

Bio intact PTH (biPTH); CaSR gene polymorphisms; Cinacalcet; Parathyroid hormone; Primary hyperparathyroidism

Indexed keywords

ALANINE; ARGININE; CALCIMIMETIC AGENT; CALCIUM; CALCIUM ION; CALCIUM SENSING RECEPTOR; CINACALCET; GLUTAMIC ACID; GLUTAMINE; GLYCINE; NPS 1493; PARAREG; PARATHYROID HORMONE; PHOSPHATE BINDING AGENT; SERINE; VITAMIN D;

ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL TRIAL; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE REGIMEN; EXON; FOOD DRUG INTERACTION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HORMONE RELEASE; HUMAN; HYPERCALCEMIA; HYPOCALCEMIA; NAUSEA; PARATHYROID CARCINOMA; PARATHYROID CELL; PARATHYROID HORMONE BLOOD LEVEL; PRIMARY HYPERPARATHYROIDISM; SECONDARY HYPERPARATHYROIDISM; SINGLE NUCLEOTIDE POLYMORPHISM; TONIC CLONIC SEIZURE;

EID: 33744811749     PISSN: 15701603     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016006776286828     Document Type: Article

References (32)

1. Bai, M. (1999) Structure and function of the extracellular calcium-sensing receptor (review). Int. J. Mol. Med. 4, 115-125.
2. Block, G. A.; Coyne, D. W. and Goodman, W. G. (2002) The calcimimetic AMG 073: a potential novel therapy for secondary hyperparathyroidism. Proc. Ann. Meeting Am. Soc. Nephrol. Philadelphia, PA, USA. SU-PO509.
3. Bollerslev, J.; Wilson, S. G.; Dick, M.; Devine, A.; Dhaliwal, S. S. and Prince, R. L. (2004) Calcium-sensing receptor gene polymorphism A986S does not predict serum calcium level, bone mineral density, calcaneal ultrasound indices, or fracture rate in a large cohort of elderly women. Calcif Tissue Int. 74, 12-7.
4. Brown, E. M.; Pollak, M. and Hebert, S. C. (1995) Sensing of extracellular Ca2+ by parathyroid and kidney cells: cloning and characterization of an extracellular Ca(2+)-sensing receptor. Am. J. Kidney Dis. 25, 506-13. Review.
5. Canaff, L.; Petit, J. L.; Kisiel, M.; Watson, P. H.; Gascon-Barre, M. and Hendy, G. N. (2001) Extracellular calcium-sensing receptor is expressed in rat hepatocytes. coupling to intracellular calcium mobilization and stimulation of bile flow. J. Biol. Chem. 276, 4070-4079.
6. Cetani, F.; Pardi, E.; Borsari, S.; Vignali, E.; Dipollina, G.; Braga, V.; Adami, S.; Pinchera, A. and Marcocci, C. (2003) Calcium-sensing receptor gene polymorphism is not associated with bone mineral density in Italian postmenopausal women. Eur. J. Endocrinol. 148, 603-607.
7. Cole, D. E. C.; Peltekova, V. D.; Vieth, R.; Hwang, D.; Hendy, G. N.; Rubin, L. A.; Evrovski J. and Hawker, G. A. (1999) Ala986Ser polymorphism of the calcium-sensing receptor and circulating calcium concentrations Lancet 353, 112-115.
8. Garner, S. C.; Pi, M.; Tu, Q. and Quarles, L. D. (2001) Rickets in cation-sensing receptor-deficient mice: an unexpected skeletal phenotype. Endocrinology 142, 3996-4005.
9. Goodman, W. G.; Hladik, G. A.; Turner, S. A.; Blaisdell, P. W.; Goodkin, D. A.; Liu, W.; Barri, Y. M.; Cohen, R. M. and Coburn, J. W. (2002) The Calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in patients with secondary hyperparathyroidism. J. Am. Soc. Nephrol. 13, 10176.
10. Gupta, A.; Kallenbach, L. R.; Zasuwa, G. and Divine, G. W. (2000) Race is a major determinant of secondary hyperparathyroidism in uremic patients. J. Am. Soc. Nephrol. 11, 330-334.
11. Johnson, C. A. (2002) Analysis of renal bone disease treatment in dialysis patients. Am. J. Kidney Dis. 39, 1270-1277.
12. Kameda, T.; Mano, H.; Yamada, Y.; Takai, H.; Amizuka, N.; Kobori, M.; Izumi, N.; Kawashima, H.; Ozawa, H.; Ikeda, K.; Kameda, A.; Hakeda, Y. and Kumegawa, M. (1998) Calcium-sensing receptor in mature osteoclasts, which are bone resorbing cells. Biochem. Biophys. Res. Commun. 245, 419-422.
13. 986Ser polymorphism of calcium-sensing receptor. Lancet 353, 1274-1278.
14. Lindberg, J. S.; Moe, S. M.; Goodman, W. G.; Coburn, J. W.; Sprague, S. M.; Liu, W.; Blaisdell, P. W.; Brenner, R. M.; Turner, S. A. and Martin, K. J. (2003) The calcimimetic AMG 073 reduces parathyroid hormone and calcium × phosphorus in secondary hyperparathyroidism. Kidney Int. 63, 248-254.
15. Lorentzon, M.; Lorentzon, R.; Lerner, U. H. and Nordstrom, P. (2001) Calcium sensing receptor gene polymorphism, circulating calcium concentrations and bone mineral density in healthy adolescent girls. Eur. J. Endocrinol. 144, 257-261.
16. Miedlich, S.; Lamesch, P.; Mueller, A. and Paschke, R. 2001 Frequency of the calcium-receptor variant A986S in patients with primary hyperparathyroidism. (2001) Eur. J. Endocrinol. 145, 421-427.
17. Mo, X. V.; Zhang, Y. Y.; Lei, S. F. and Deng, H. W. (2004) A986S polymorphism of calcium-sensing receptor gene is not related to bone mineral density or bone size in premenopausal Chinese women. Di Yi Jun Yi Da Xue Xue Bao 24, 1097-1101, Chinese.
18. Nemeth, E. F.; Heaton, W. H. and Miller, M. (2004) Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl. J. Pharmacol. Exp. Ther. 308(2), 627-635.
19. Owda, A.; Elhwairis, H.; Narra, S.; Towery, H. and Osama, S. (2003) Secondary hyperparathyroidism in chronic hemodialysis patients: prevalence and race. Ren. Fail 25, 595-602.
20. Pi, M.; Hinson, T. K. and Quarles, L. (1999) Failure to detect the extracellular calcium, sensing receptor (CasR) in human osteoblast cell lines. J. Bone Miner Res. 14, 1310-1319.
21. Riccardi, D. and Gamba, G. (1999) The many roles of the Calcium-sensing receptor in health and disease. Arch. Med. Res. 30, 436-448.
22. 990Gly and its possible effect on response to cinacalcet HCl. Pharmacogenet. Genomics. 15, 29-34.
23. 990Gly influences the response to a single dose of cinacalcet HCl. JASN 16, 66A.
24. 990Gly influences the severity of secondary hyperparathyroidism in hemodialysis patients JASN 16, 752A.
25. Rubin, L. A.; Peltekova, V.; Janicic, N.; Liew, C.; Hwang, D.; Evrovski, J.; Hendy, G. N. and Cole, D. E. C. (1997) Calcium-sensing receptor gene: analysis of polymorphism frequency. Scand. J. Clin. Lab Invest. 57, 122-125.
26. 986S" polymorphism and bone mineral density in Hungarian postmenopausal women. Bone 30, 849-852.
27. Vezzoli, G.; Tanini, A.; Ferruci; Soldati, L.; Bianchini, C.; Franceschelli, F.; Malentachi, C.; Porfirio; Adamo, D.; Terranegra, D.; Falchetti, A.; Cusi, D.; Bianchi, G. and Brand, M. L. (2002) Influence of Calcium-Sensing Receptor Gene on Urinary Calcium Excretion in Stone-Forming Patients. J. Am. Soc. Nephrol. 13, 2517-2523.
28. Vincenti, F.; Hattner, R.; Amend, W. J. Jr; Feduska, N. J.; Duca, R. M. and Salvatierra, O. Jr. (1981) Decreased secondary hyperparathyroidism in diabetic patients receiving hemodialysis JAMA 6;235(9), 930-933.
29. Wada, M.; Ishii, H.; Furuya, Y.; Fox, J.; Nemeth, E. F. and Nagano, N. (1998) NPS R-568 halts or reverses osteitis fibrosa in uremic rats. Kidney Int. 53, 448-453.
30. Yamauchi, M.; Sugimoto, T.; Yamaguchi, T.; Yano, S.; Kanzawa, M.; Kobayashi, A. and Chihara, K. (2001) Association of polymorphic alleles of the calcium-sensing receptor gene with the clinical severity of primary hyperparathyroidism. Clin. Endocrinol. 55, 373-379.
31. Yokoyama, K.; Shigematsu, T.; Tsukada, T.; Hara, S.; Yamada, S.; Kawaguchi, Y. and Hosoya, T. (2002) Calcium-sensing receptor gene polymorphism affects the parathyroid response to moderate hypercalcemic suppression in patients with end-stage renal disease. Clin. Nephrology 57, 131-135.
32. Young, R.; Wu, F.; Van de water, N.; Ames, R.; Gamble, G. and Reid, I. R. (2003) Calcium-sensing receptor gene polymorphism and responsiveness to calcium supplementation in postmenopausal women. J. Clin. Endocrinol. Metab. 88, 697-700.